Differential effects of androgens on cortical bone histomorphometry in gonadectomized male and female rats
β Scribed by Dr. Russell T. Turner; Glenn K. Wakley; Kathleen S. Hannon
- Publisher
- Elsevier Science
- Year
- 1990
- Tongue
- English
- Weight
- 552 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0736-0266
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
The physiological role of gonadal androgens in regulating bone metabolism is not established. To determine if androgens antagonize the changes in cortical bone after gonadectomy, we treated orchiectomized (ORX) rats with testosterone (T) and 5Ξ±βdihydrotestosterone (DHT), and ovariectomized (OVX) rats with the aforeβmentioned androgens, as well as the synthetic androgen fluoxymesterone (FI) and the nonsteroidal estrogen diethylstilbestrol (DES). OVX resulted in a rapid, sustained increase in periosteal bone formation at the tibial diaphysis, whereas ORX resulted in decreased bone formation. Androgen treatment stimulated bone formation in ORX rats and suppressed bone formation in OVX rats. A large dose of DES suppressed bone formation in OVX rats to values below the intact controls. The results of these studies demonstrate that androgens counteract the changes in cortical bone formation after gonadectomy in females as well as males, and thereby reestablish the sex difference observed in intact rats.
π SIMILAR VOLUMES
Histomorphometry was performed in iliac crest biopsies from 15 female-to-male (F-M) transsexuals with a mean age of 30 e 6.1 (SD) years. At the time of study, they had been treated with parenteral testosterone esters (250 mg/2 weeks) or oral testosterone undecanoate (160 mglday). The median androgen
Gender differences in hepatic sex steroid and drug metabolism result from hormonal regulation of specific cytochrome P450 genes (CYP). In male rats, bile duct ligation (BDL) is associated with down-regulation of the male-specific genes, CYP2C11 and CYP3A2, together with a decrease in serum testoster